ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1895

Sacroiliitis at Diagnosis in Children with Juvenile Spondyloarthritis

Pamela Weiss1, Rui Xiao2,3 and Nancy Chauvin4, 1Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Philadelphia, PA, 2Department of Pediatrics, Division of Biostatistics, Children's Hospital of Philadelphia, Philadelphia, PA, 3Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA, 4Radiology, Children's Hospital of Philadelphia, Philadelphia, PA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: axial spondyloarthritis, MRI, pediatric rheumatology and spondylarthritis

  • Tweet
  • Email
  • Print
Session Information

Title: Imaging of Rheumatic Diseases: X-ray, MRI and CT

Session Type: Abstract Submissions (ACR)

Background/Purpose

The prevalence of sacroiliitis in children with juvenile spondyloarthritis (JSpA) at diagnosis is unknown. We aimed to evaluate: 1) the prevalence of sacroiliitis at diagnosis using radiographs and MRI; and 2) the association of physical examination and a history of back pain with acute sacroiliitis, using MRI as the reference standard.

Methods

We performed a single center prospective cross-sectional study of 39 children with newly diagnosed JSpA. Children were eligible for inclusion if they were diagnosed with enthesitis-related arthritis (ERA) or psoriatic arthritis (PsA) according to the International League of Associations for Rheumatology criteria in the prior 6 months. On the same day subjects had a musculoskeletal examination and imaging, which included a single AP pelvic radiograph and a non-contrast pelvic MRI with STIR. Radiographs were scored using the modified New York criteria. Acute sacroiliitis on MRI was defined as bone marrow edema within the sacrum or adjacent ilium with or without accompanying capsulitis, enthesitis, or effusion. Univariate logistic regression was used to test the association of clinical factors with acute sacroiliitis.  

Results

Mean age of the JSpA subjects was 14.0 ± 2.7 years. 49% were male and 44% were HLA-B27+. 35 and 4 children met criteria for ERA and psoriatic arthritis, respectively. Nine (23%) children had acute sacroiliitis; in 5 subjects it was bilateral. Of the 9 children with acute sacroiliitis on MRI, 7 (78%) had erosions or sclerosis on MRI and 5 (56%) had changes on conventional radiography. 2 subjects met radiologic criteria for ankylosing spondylitis. Of the subjects with acute sacroiliitis only 4 (44%) reported a history of back pain or tenderness on palpation of the sacroiliac joints. 3 (33%) and 14 (47%) of children with JSpA with and without sacroiliitis met the ASAS inflammatory back pain criteria. Male sex, hip arthritis, alternating buttock pain, higher c-reactive protein, HLA-B27 positivity, and decreased lateral flexion were associated with a higher odds of acute sacroiliitis, albeit statistically insignificant (Table).

Conclusion

This is the first study reporting the prevalence of acute sacroiliitis at diagnosis in children with JSpA. Sacroiliitis is common at diagnosis and may be asymptomatic. Nearly half the cases of sacroiliitis would have been missed if radiographs were the only imaging modality.

Table. Clinical features in MRI+ and MRI- subjects (N=39)

Clinical Feature

MRI+

N=9

N (%)

MRI-

N=30

N (%)

p-value+

OR of acute sacroiliitis

(95% CI)

Psoriatic arthritis

1 (25)

3 (75)

0.92

—

Enthesitis-related

arthritis

8 (23)

27 (77)

0.92

—

Age (years),

mean±SD

14.0 ±2.7

14.0 ±2.7

0.97

1.00 (0.75, 1.32)

Male

6 (67)

13 (43)

0.20

2.62 (0.55,12.48)

AJC at diagnosis,

mean±SD

1.1±1.7

3.4±5.4

0.22

0.79 (0.52, 1.22)

Tender enthesitis

count at diagnosis,

mean±SD

3.4±3.7

4.2±4.2

0.63

0.95 (0.78, 1.16)

Hip arthritis

1 (11)

3 (10)

0.92

   1.13 (0.10, 12.36)

Patient-reported

Back pain

4 (44)

18 (60)

0.68

0.53 (0.12, 2.40)

Back pain ≥ 3 months

2 (22)

10 (33)

0.84

0.57 (0.10, 3.27)

Insidious onset of back pain

2 (22)

11 (37)

0.42

0.49 (0.09, 2.81)

Back pain Improves with activity

2 (22)

7 (23)

0.95

0.94 (0.16, 5.59)

Alternating buttock pain

3 (33)

6 (20)

0.41

1.68 (0.38, 10.40)

AM back stiffness >30 min

2 (22)

13 (43)

0.59

0.65 (0.14, 3.12)

Nighttime back pain

2 (22)

10 (33)

0.41

0.49 (0.08, 2.81)

Inflammatory back pain#

3 (33)

14 (47)

0.48

0.57 (0.12, 2.72)

Laboratory features

CRP at diagnosis (mg/dL)*, mean±SD

19.2 ±39.9

2.2±4.7

0.06

1.06 (0.96, 1.16)

HLA-B27+ ^

6 (75)

10(36)

0.05

5.40 (0.91, 31.93)

Physical examination

Decreased lateral flexion

5 (56)

14 (47)

0.64

     1.43 (0.32, 6.39)

Loss of lumbar lordosis

4 (44)

15 (59)

0.77

0.80 (0.18, 3.57)

Positive FABER/Patrick’s test

0 (0)

6 (20)

0.15

—

Decreased forward flexion

1 (11)

0 (0)

0.06

—

Sacroiliac tenderness

2 (22)

14 (47)

0.19

   0.33 (0.06, 1.84)

Legend. +P-value for chi-square or t-test comparisons of clinical features between subjects who had a positive or negative MRI. #ASAS inflammatory back pain (if ≥2 of the following positive: insidious onset, improvement with exercise, no improvement with rest, nocturnal pain). *CRP within 6 weeks of diagnosis available for 29 cases. ^ HLA-B27 available for 36 cases.


Disclosure:

P. Weiss,
None;

R. Xiao,
None;

N. Chauvin,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sacroiliitis-at-diagnosis-in-children-with-juvenile-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology